Non-EEA Authorized Comparator Biologics Allowed for Approval of Biosimilars in Europe

Drug Industry Daily
A A
Manufacturers seeking approval of biosimilars in Europe will be able to use comparator biologics authorized outside the EU to gain marketing clearance.

To View This Article:

Login

Subscribe To Drug Industry Daily